ACP Journal Club. In at-risk patients with type 2 diabetes, saxagliptin and placebo did not differ for CV events
published in: Annals of Internal Medicine
date of publication: 2014-01-01
language: English
main subject: type 2 diabetes, placebo
Cites articles
There is nothing here
Article - wd:Q87133809